GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PharmX Technologies Ltd (ASX:PHX) » Definitions » Quick Ratio

PharmX Technologies (ASX:PHX) Quick Ratio : 5.35 (As of Dec. 2024)


View and export this data going back to 1973. Start your Free Trial

What is PharmX Technologies Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. PharmX Technologies's quick ratio for the quarter that ended in Dec. 2024 was 5.35.

PharmX Technologies has a quick ratio of 5.35. It generally indicates good short-term financial strength.

The historical rank and industry rank for PharmX Technologies's Quick Ratio or its related term are showing as below:

ASX:PHX' s Quick Ratio Range Over the Past 10 Years
Min: 1.37   Med: 1.92   Max: 5.35
Current: 5.35

During the past 13 years, PharmX Technologies's highest Quick Ratio was 5.35. The lowest was 1.37. And the median was 1.92.

ASX:PHX's Quick Ratio is ranked better than
90.92% of 683 companies
in the Healthcare Providers & Services industry
Industry Median: 1.27 vs ASX:PHX: 5.35

PharmX Technologies Quick Ratio Historical Data

The historical data trend for PharmX Technologies's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmX Technologies Quick Ratio Chart

PharmX Technologies Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.78 1.63 1.67 1.84 1.37

PharmX Technologies Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.68 1.84 1.37 1.37 5.35

Competitive Comparison of PharmX Technologies's Quick Ratio

For the Health Information Services subindustry, PharmX Technologies's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmX Technologies's Quick Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PharmX Technologies's Quick Ratio distribution charts can be found below:

* The bar in red indicates where PharmX Technologies's Quick Ratio falls into.


;
;

PharmX Technologies Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

PharmX Technologies's Quick Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Quick Ratio (A: Jun. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(16.369-0)/11.95
=1.37

PharmX Technologies's Quick Ratio for the quarter that ended in Dec. 2024 is calculated as

Quick Ratio (Q: Dec. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(5.668-0)/1.059
=5.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmX Technologies  (ASX:PHX) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


PharmX Technologies Quick Ratio Related Terms

Thank you for viewing the detailed overview of PharmX Technologies's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmX Technologies Business Description

Traded in Other Exchanges
N/A
Address
17 Castlereagh Street, Suite 11.02, Level 11, Sydney, NSW, AUS, 2000
PharmX Technologies Ltd is an Australia-based software and technology company. The company has a single segment which is Health Services. In Health services, the company develops and distributes business software for the pharmacy industry with particular emphasis on point-of-sale and pharmaceutical dispensing software, support services, and associated computer hardware. It derives a majority of its revenue from the Health services business.